BDLIB
AZN icon

Banque de Luxembourg Investments (BLI)’s AstraZeneca AZN Stock Holding History

Banque de Luxembourg Investments (BLI)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.3M Sell
370,958
-1,911
-0.5% -$359K 2.41% 10
2026
Q1 		$69M Buy
+372,869
New +$71.9M 2.07% 11

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Banque de Luxembourg Investments (BLI)'s AZN Position: Q2 2026 in Review

Banque de Luxembourg Investments (BLI) reduced its AstraZeneca (AZN) stake by 0.51% in Q2 2026, selling an estimated $359K and leaving 370,958 shares worth $68.3M. The position accounts for 2.41% of the portfolio, ranked #10.

Banque de Luxembourg Investments (BLI) first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $69M in Q1 2026. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Banque de Luxembourg Investments (BLI) held 370,958 shares of AstraZeneca worth $68.3M as of Q2 2026.
  • Banque de Luxembourg Investments (BLI) sold 1,911 AstraZeneca shares in Q2 2026, an estimated $359K.
  • AstraZeneca made up 2.41% of Banque de Luxembourg Investments (BLI)'s portfolio in Q2 2026, its #10 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • Banque de Luxembourg Investments (BLI)'s AstraZeneca position peaked at $69M in Q1 2026.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q2 2026, filed 10 Aug 2026.